Alvotech’s Q2 loss exceeded analyst estimates by $0.05 per share, despite revenue beating expectations.
Alvotech reported a Q2 loss of $0.11 per share, missing the Zacks Consensus Estimate of a $0.06 loss. The wider-than-expected deficit contrasts with earnings of $0.14 per share in the same period last year.
Analysts had anticipated a narrower loss, but the company’s adjusted figures still reflect a year-over-year decline. Revenue performance, however, surpassed estimates, offering a mixed signal for investors.
Shares may face pressure as the deeper loss overshadows the revenue beat, though market reaction remains to be seen.